Left ventricular remodelling is the process by which the heart’s structure, geometry and function change in response to myocardial infarction. Following an infarct, irreversible loss of cardiomyocytes ...

Aims Mineralocorticoid receptor (MR) antagonists improve cardiovascular outcomes in patients with heart failure complicating acute myocardial infarction (AMI) and in chronic heart failure. It is ...

In patients with heart failure (HF) due to acute myocardial infarction (AMI), angiotensin receptor–neprilysin (ARN) inhibitors lower the risk for cardiovascular (CV) events, reduce HF ...

Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle is irreversibly damaged and replaced by scar tissue, which, while ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

Millions of people survive heart attacks each year, yet many go on to experience memory lapses, difficulty concentrating, and ...

Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...

Changes in heart structure and function may occur years before certain cancers are diagnosed, according to a study published ...

Heart failure (HF) affects an estimated 64.3 million people globally and approximately 8-10 million individuals in India, ...